FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Scope Fluidics Spolka Akcyjna's FCF Yield % or its related term are showing as below:
FRA:S84'
s FCF Yield % Range Over the Past 10 Years
Min: -25.04 Med: -5.43 Max: -1.1
Current: -17.45
During the past 10 years, the highest FCF Yield % of Scope Fluidics Spolka Akcyjna was -1.10%. The lowest was -25.04%. And the median was -5.43%.
FRA:S84's FCF Yield % is ranked worse than 78.04% of 214
companies
in the Medical Diagnostics & Research industry
Industry Median: -1.475
vs FRA:S84: -17.45
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Scope Fluidics Spolka Akcyjna FCF Yield % Related Terms
Scope Fluidics Spolka Akcyjna FCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Scope Fluidics Spolka Akcyjna's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Scope Fluidics Spolka Akcyjna FCF Yield % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Scope Fluidics Spolka Akcyjna's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Scope Fluidics Spolka Akcyjna's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Scope Fluidics Spolka Akcyjna (FRA:S84) has a FCF Yield % of -17.45 as of Jun. 30, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Scope Fluidics Spolka Akcyjna and its competitors. According to the industry distribution chart, Scope Fluidics Spolka Akcyjna ranks #167 out of 214 companies in the Medical Diagnostics & Research industry, placing it in the top 78%.
Is Scope Fluidics Spolka Akcyjna's FCF Yield % too high?
Scope Fluidics Spolka Akcyjna's current FCF Yield % is -17.45. Based on the distribution chart, Scope Fluidics Spolka Akcyjna ranks #167 out of 214 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Scope Fluidics Spolka Akcyjna has a GF Score™ of 45/100, reflecting its overall financial health beyond just this single metric.
How does Scope Fluidics Spolka Akcyjna's FCF Yield % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Scope Fluidics Spolka Akcyjna ranks #167 out of 214 companies for FCF Yield %. This places Scope Fluidics Spolka Akcyjna in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Diagnostics & Research company?
A good FCF Yield % depends on the Medical Diagnostics & Research industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Scope Fluidics Spolka Akcyjna and its competitors. Scope Fluidics Spolka Akcyjna's current FCF Yield % is -17.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scope Fluidics Spolka Akcyjna stock overvalued right now?
Scope Fluidics Spolka Akcyjna (FRA:S84) has a current FCF Yield % of -17.45. The stock's GF Value™ is €26.71, compared to a current price of €24.00 — trading 10.1% below its estimated fair value. The current FCF Yield % is -17.45. Scope Fluidics Spolka Akcyjna's overall GF Score™ is 45/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Scope Fluidics Spolka Akcyjna (FRA:S84), the current FCF Yield % is -17.45 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Scope Fluidics Spolka Akcyjna (FRA:S84) Overvalued in 2026?
Based on GuruFocus' analysis, Scope Fluidics Spolka Akcyjna stock appears to be undervalued.
The current stock price of €24.00 is trading 10.1% below its estimated GF Value™ of €26.71.
Key valuation signals for FRA:S84:
FCF Yield %: -17.45
GF Value™: €26.71 vs. price of €24.00 (10.1% below fair value)
No single metric tells the full story. See the FRA:S84 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Scope Fluidics Spolka Akcyjna Business Description
Scope Fluidics Spolka Akcyjna focuses on global challenges in health to develop diagnostic and med tech solutions. The company combines the expertise in microfluidic technology with the awareness of the challenges in medical diagnostics. It provides prototyping support for diagnostic services.
45GF Score
Get the complete analysis for FRA:S84
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:S84 has been successfully added to your 
